FREDERICK, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Decentralized Trials & Research Alliance brings together Global Leaders for its Annual Meeting SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE)...
- Third quarter revenue of $12.2M, +49% year-over-year growth- Third quarter pulse recurring revenue of $3.1M, +99% year-over-year growth- First nine...
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national...
PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics,...
SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is...
CIRM-Funded Programs to Receive Access to Avid’s Suite of World-Class CGT CDMO Services to Support Clinical Development ActivitiesTUSTIN, Calif., Nov....
Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose...
Insights from Recent Research Study Expose Significant Gaps in Standard of CareDARIEN, Conn., Nov. 08, 2023 (GLOBE NEWSWIRE) -- futuresTHRIVE,...
STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to...
Cambridge, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a...
BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development,...
- Continuing to open CONNECT1-EDO51 trial sites in Canada - - Opening of FREEDOM-DM1 trial sites underway in the U.S. and...
SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP)...
HIGH POINT, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused...
-- Dr. Gaggar is an experienced industry executive with substantial infectious disease expertise and proven record of successfully leading early-...
WARRINGTON, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
The company leads its industry in post-consumer recycled plastic and virgin plastic reductionRacine, Wisconsin--(Newsfile Corp. - November 8, 2023) -...
DEA'S MANDATE IS DRUG DIVERSION, SECURITY AND TO FACILITATE DRUG DEVELOPMENT?DEA DIRECTOR ANNE MILGRAM THINKS DIFFERENTLY. LAW ENFORCEMENT OFFICERS SUFFER.WASHINGTON,...